Severe hyperchloremic metabolic acidosis with SGLT2 inhibitors in patients with urinary diversion
Nefrología (English Edition) · 2025
DOI: 10.1016/j.nefroe.2024.12.005 ↗Kurz gefasst
Fallbericht in der Zeitschrift Nefrología (English Edition), 2025. Verfasst von Carolina Gomes und 5 weiteren Autor:innen. Beteiligte Einrichtung: Hospital of Vila Franca de Xira Lisboa, Portugal. Electronic address: carolinagomes12@hotmail.com. Hauptthemen laut MEDLINE: Sodium-Glucose Transporter 2 Inhibitors, Acidosis, Urinary Diversion, Postoperative Complications. Die Arbeit nennt 3 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Urinary diversion after cystectomy using autologous intestinal segments has been the gold standard treatment in several urinary tract diseases. The most frequent metabolic consequence is hyperchloremic metabolic acidosis, due to ammonium hydrogen and chloride ions absorption in exchange for the excretion of bicarbonate and sodium ions in the bowel conduit. Sodium-glucose co-transporter-2 (SGLT2) inhibitors are a class of antihyperglycemic agents that block the reabsorption of filtered glucose in the renal proximal convoluted tubules, promoting greater urinary glucose and sodium excretion. The authors describe two cases of patients with bowel conduit and mild/severe hyperchloremic metabolic acidosis, after starting SGLT2 inhibitors. Both were presented with mild acute kidney injury, moderate hyperglycemia, normal ketoacids, normal lactate and normal anion gap. Clinical and laboratory normalization were reached after this drug was withdrawn and fluid support therapy was applied. We hypothesize that SGLT2 inhibitors could exacerbate chronic hyperchloremic metabolic acidosis in these patients, by enhance sodium loss and volume depletion, subsequent acute kidney injury (AKI), increase renal chloride elimination due to sodium loss and subsequent chloride/bicarbonate bowel exchange. Rebound hyperglycemia due to bowel absorption and bicarbonate renal elimination through Na+-H+exchanger 3 (NHE3) suppression, could also contribute. This association needs further investigation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Hospital of Vila Franca de Xira Lisboa, Portugal. Electronic address: carolinagomes12@hotmail.com.
- Hospital of Vila Franca de Xira Lisboa, Portugal.
Zitieren
APA
Gomes, C., Barbosa Barroso, J., Oliveira, A. I., Guerreiro Cruz, S., Cunha, L., & Azevedo, A. (2025). Severe hyperchloremic metabolic acidosis with SGLT2 inhibitors in patients with urinary diversion. Nefrología (English Edition). https://doi.org/10.1016/j.nefroe.2024.12.005
Vancouver
Gomes C, Barbosa Barroso J, Oliveira AI, Guerreiro Cruz S, Cunha L, Azevedo A. Severe hyperchloremic metabolic acidosis with SGLT2 inhibitors in patients with urinary diversion. Nefrología (English Edition). 2025. doi:10.1016/j.nefroe.2024.12.005
BibTeX
@article{Gomes2025,
author = {Gomes, Carolina and Barbosa Barroso, João and Oliveira, Ana Isabel and Guerreiro Cruz, Sofia and Cunha, Liliana and Azevedo, Ana},
title = {Severe hyperchloremic metabolic acidosis with SGLT2 inhibitors in patients with urinary diversion},
journal = {Nefrología (English Edition)},
year = {2025},
doi = {10.1016/j.nefroe.2024.12.005}
}
EUVIMED